Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.

Young A, Ngiow SF, Gao Y, Patch AM, Barkauskas DS, Messaoudene M, Lin G, Coudert JD, Stannard KA, Zitvogel L, Degli-Esposti MA, Vivier E, Waddell N, Linden J, Huntington ND, Souza-Fonseca-Guimaraes F, Smyth MJ.

Cancer Res. 2018 Feb 15;78(4):1003-1016. doi: 10.1158/0008-5472.CAN-17-2826. Epub 2017 Dec 11.

2.

"Natural Regulators": NK Cells as Modulators of T Cell Immunity.

Schuster IS, Coudert JD, Andoniou CE, Degli-Esposti MA.

Front Immunol. 2016 Jun 14;7:235. doi: 10.3389/fimmu.2016.00235. eCollection 2016. Review.

3.

Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.

Forbes CA, Scalzo AA, Degli-Esposti MA, Coudert JD.

J Immunol. 2016 Jul 1;197(1):128-40. doi: 10.4049/jimmunol.1600199. Epub 2016 May 27.

4.

A natural genetic variant of granzyme B confers lethality to a common viral infection.

Andoniou CE, Sutton VR, Wikstrom ME, Fleming P, Thia KY, Matthews AY, Kaiserman D, Schuster IS, Coudert JD, Eldi P, Chaudhri G, Karupiah G, Bird PI, Trapani JA, Degli-Esposti MA.

PLoS Pathog. 2014 Dec 11;10(12):e1004526. doi: 10.1371/journal.ppat.1004526. eCollection 2014 Dec.

5.

TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity.

Schuster IS, Wikstrom ME, Brizard G, Coudert JD, Estcourt MJ, Manzur M, O'Reilly LA, Smyth MJ, Trapani JA, Hill GR, Andoniou CE, Degli-Esposti MA.

Immunity. 2014 Oct 16;41(4):646-56. doi: 10.1016/j.immuni.2014.09.013.

6.

Ly49C-dependent control of MCMV Infection by NK cells is cis-regulated by MHC Class I molecules.

Forbes CA, Scalzo AA, Degli-Esposti MA, Coudert JD.

PLoS Pathog. 2014 May 29;10(5):e1004161. doi: 10.1371/journal.ppat.1004161. eCollection 2014 May.

7.

Targeting of a natural killer cell receptor family by a viral immunoevasin.

Berry R, Ng N, Saunders PM, Vivian JP, Lin J, Deuss FA, Corbett AJ, Forbes CA, Widjaja JM, Sullivan LC, McAlister AD, Perugini MA, Call MJ, Scalzo AA, Degli-Esposti MA, Coudert JD, Beddoe T, Brooks AG, Rossjohn J.

Nat Immunol. 2013 Jul;14(7):699-705. doi: 10.1038/ni.2605. Epub 2013 May 12.

PMID:
23666294
8.

Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells.

Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, Chen L, Mécheri S, Kaplanski G, Prévost-Blondel A, Kato M, Schultze JL, Tartour E, Kroemer G, Degli-Esposti M, Chaput N, Zitvogel L.

Cancer Res. 2012 Jun 1;72(11):2757-67. doi: 10.1158/0008-5472.CAN-11-3379. Epub 2012 Mar 16.

9.

Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation.

Corbett AJ, Coudert JD, Forbes CA, Scalzo AA.

J Immunol. 2011 Feb 1;186(3):1713-22. doi: 10.4049/jimmunol.1003308. Epub 2010 Dec 27.

10.

Killers and beyond: NK-cell-mediated control of immune responses.

Andoniou CE, Coudert JD, Degli-Esposti MA.

Eur J Immunol. 2008 Nov;38(11):2938-42. doi: 10.1002/eji.200838882. Review.

11.

Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells.

Laffont S, Seillet C, Ortaldo J, Coudert JD, Guéry JC.

Blood. 2008 Aug 1;112(3):661-71. doi: 10.1182/blood-2007-10-120089. Epub 2008 May 27.

12.

Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways.

Coudert JD, Scarpellino L, Gros F, Vivier E, Held W.

Blood. 2008 Apr 1;111(7):3571-8. doi: 10.1182/blood-2007-07-100057. Epub 2008 Jan 15.

PMID:
18198346
13.

Interactions of Ly49 family receptors with MHC class I ligands in trans and cis.

Scarpellino L, Oeschger F, Guillaume P, Coudert JD, Lévy F, Leclercq G, Held W.

J Immunol. 2007 Feb 1;178(3):1277-84.

14.

T and B lymphocytes exert distinct effects on the homeostasis of NK cells.

Jeannet G, Coudert JD, Held W.

Eur J Immunol. 2006 Oct;36(10):2725-34.

15.

The role of the NKG2D receptor for tumor immunity.

Coudert JD, Held W.

Semin Cancer Biol. 2006 Oct;16(5):333-43. Epub 2006 Jul 8. Review.

PMID:
16914326
16.

CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo.

Laffont S, Coudert JD, Garidou L, Delpy L, Wiedemann A, Demur C, Coureau C, Guéry JC.

Blood. 2006 Oct 1;108(7):2257-64. Epub 2006 Jan 31.

PMID:
16449531
17.

Cooperating pre-T-cell receptor and TCF-1-dependent signals ensure thymocyte survival.

Goux D, Coudert JD, Maurice D, Scarpellino L, Jeannet G, Piccolo S, Weston K, Huelsken J, Held W.

Blood. 2005 Sep 1;106(5):1726-33. Epub 2005 May 12.

PMID:
15890681
18.

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.

Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, Held W.

Blood. 2005 Sep 1;106(5):1711-7. Epub 2005 May 10.

PMID:
15886320
19.

Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.

Held W, Chalifour A, Coudert JD.

Med Microbiol Immunol. 2005 Aug;194(4):169-74. Epub 2005 Jan 20. Review. No abstract available.

PMID:
15660246
20.

Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells.

Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A, Dupont S, Chambon P, Druet P, Bayard F, Guéry JC.

Eur J Immunol. 2003 Feb;33(2):512-21.

21.

The NK cell receptor repertoire: formation, adaptation and exploitation.

Held W, Coudert JD, Zimmer J.

Curr Opin Immunol. 2003 Apr;15(2):233-7. Review.

PMID:
12633675
22.

Anti-mu-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: evidence for a role in apoptotic immune cell death.

Macé G, Jaume M, Blanpied C, Stephan L, Coudert JD, Druet P, Dietrich G.

Blood. 2002 Nov 1;100(9):3261-8.

PMID:
12384426
24.
25.

Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I-T-cell interactions.

Coudert JD, Foucras G, Demur C, Coureau C, Mazerolles C, Delsol G, Druet P, Guéry JC.

J Clin Invest. 2000 Apr;105(8):1125-32. Erratum in: J Clin Invest 2000 Jul;106(1):157.

Supplemental Content

Loading ...
Support Center